journal cover

The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus

Expert Opinion on Pharmacotherapy

Dec 18, 2013

Yuri OnoHiroshi Nomoto

Abstract

Meal tolerance tests (MTTs) are usually conducted at breakfast after overnight fasting in type 2 diabetes mellitus (T2DM) patients, but differences in postprandial glycemic responses between meals have been reported. We conducted MTTs at breakfast, lunch, and dinner to examine the effec...read more

Mentioned in this Paper

Voglibose
Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Glucagon (rDNA)
Lunch
C-Peptide
Nonesterified Fatty Acids Measurement
Glucagon
Mealtimes
Glucagon-Like Peptide 1
1
6
Paper Details
References
  • References25
  • Citations3
123

Similar Papers Found In These Feeds

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Neuropeptides

There are >50 peptides released by neurons that function as neuromodulators, neurotransmitters, neurohormones, and hormones. Here is the latest research on the systemic function of neuropeptides in the body.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

GLP-1 Signaling

GLP-1 signaling pathway has been well studied for its role in regulating glucose homeostasis, as well as its beneficial effects in energy and nutrient metabolism. Discover the latest research on this signaling pathway here.

Nutrition & Aging

Nutrition improves health and well-being and is one of the important determining factors in successful aging. The mechanism by which nutrition plays a roll in aging is still being unveiled. Discover the latest research on nutrition and aging here.

© 2020 Meta ULC. All rights reserved

The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus

Expert Opinion on Pharmacotherapy

Dec 18, 2013

Yuri OnoHiroshi Nomoto

PMID: 24328511

DOI: 10.1517/14656566.2014.868437

Abstract

Meal tolerance tests (MTTs) are usually conducted at breakfast after overnight fasting in type 2 diabetes mellitus (T2DM) patients, but differences in postprandial glycemic responses between meals have been reported. We conducted MTTs at breakfast, lunch, and dinner to examine the effec...read more

Mentioned in this Paper

Voglibose
Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Glucagon (rDNA)
Lunch
C-Peptide
Nonesterified Fatty Acids Measurement
Glucagon
Mealtimes
Glucagon-Like Peptide 1
1
6

Similar Papers Found In These Feeds

Type 2 Diabetes

This feed focuses on Type 2 Diabetes, a disease where the body doesn’t produce or respond to insulin anymore, leading to abnormal glucose levels in the blood.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Paper Details
References
  • References25
  • Citations3
123
/papers/the-glycemicmetabolic-responses-to-meal-tolerance/24328511